OLAPARIB DOSE REDUCTION IN PLATINUM-SENSITIVE OVARIAN CANCER RECURRENCE: REAL-WORLD DATA

被引：0
|
作者：
Boccia, Serena Maria [1 ]
Culcasi, Camilla [1 ]
Sassu, Carolina Maria [1 ]
Guida, Fiorenza [1 ]
Apostol, Adriana Ionelia [1 ]
Vertechy, Laura [1 ]
Ferrandina, Gabriella [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
机构：
[1] IRCCS, Dipartimento Sci Salute Donna Bambino & Sanit Pu, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Sci Vita & Sanit Pubbl, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
887
引用
收藏
页码：A319 / A319
页数：1
相关论文
共 50 条
  • [31] Management of platinum-sensitive recurrent ovarian cancer
    Pfisterer, Jacobus
    Ledermann, Jonathan A.
    SEMINARS IN ONCOLOGY, 2006, 33 (02) : S12 - S16
  • [32] Efficacy and safety of olaparib, olaparib plus bevacizumab and niraparib maintenance treatment in Japanese patients with platinum-sensitive advanced ovarian cancer
    Nakamura, Keiichiro
    Matsuoka, Hirofumi
    Yorimitsu, Masae
    Ogawa, Mariko
    Kanemori, Miho
    Sueoka, Kotaro
    Kozai, Ayumi
    Nakamura, Hiroko
    Haruma, Tomoko
    Shiroyama, Yuko
    Hayata, Yuu
    Sugii, Hirokazu
    Ueda, Akiko
    Kurihara, Shuichi
    Urayama, Saiko
    Shimizu, Miyuki
    Masuyama, Hisashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 31 - 37
  • [33] Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
    Wu, Lei
    Zhong, Lixian
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 187 - 195
  • [34] Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
    Liu, Joyce F.
    Barry, William T.
    Birrer, Michael
    Lee, Jung-Min
    Buckanovich, Ronald J.
    Fleming, Gini F.
    Rimel, B. J.
    Buss, Mary K.
    Nattam, Sreenivasa
    Hurteau, Jean
    Luo, Weixiu
    Quy, Philippa
    Whalen, Christin
    Obermayer, Lisa
    Lee, Hang
    Winer, Eric P.
    Kohn, Elise C.
    Ivy, S. Percy
    Matulonis, Ursula A.
    LANCET ONCOLOGY, 2014, 15 (11): : 1207 - 1214
  • [35] Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Zhong, Lixian
    Anh Thu Tran
    Tomasino, Taylor
    Nugent, Elizabeth
    Smith, Judith A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (12): : 1219 - 1228
  • [36] Real-life data: Women with recurrent platinum-sensitive ovarian cancer and BCARGEM treatment.
    van der Scheun, Frederique C.
    Bruijnen, Cheryl P.
    Witteveen, Petronella
    Suelmann, Britt B. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Real-Life Data of Niraparib Maintenance Treatment in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 10 - 11
  • [38] Sleep characteristics and recurrence in platinum-sensitive ovarian cancer survivors: A prospective cohort study
    Benoit, Melanie
    Sylvestre, Marie-Pierre
    Datta, Geetanjali
    Gilbert, Lucy
    Ho, Vikki
    Karp, Igor
    Lacaille, Julie
    Lau, Susie
    Samouelian, Vanessa
    Koushik, Anita
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 56
  • [39] CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase-2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
    Lee, Jung-Min
    Trepel, Jane B.
    Choyke, Peter
    Cao, Liang
    Sissung, Tristan
    Houston, Nicole
    Yu, Minshu
    Figg, William D.
    Turkbey, Ismail Baris
    Steinberg, Seth M.
    Lee, Min-Jung
    Ivy, S. Percy
    Liu, Joyce F.
    Matulonis, Ursula A.
    Kohn, Elise C.
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [40] Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
    Della Pepa, Chiara
    Banerjee, Susana
    ONCOTARGETS AND THERAPY, 2014, 7 : 1025 - 1032
12345